ReEmerge raised $37 million in Series A funding.
- Amount
- $37M
- Stage
- Series A
- Announced
- 15 September 2026
- Leads
- U.S. Venture Partners, Santé
- Other investors
- Oxford Science Enterprises, 415 Capital, IAG Capital Partners, The Vertical Group, Dendrion Ventures
- Use of funds
- Support an upcoming clinical study evaluating CNRT in traumatic brain injury, while advancing technology development, expanding clinical and regulatory operations.
- Checked
- Amount and date checked against the press source